BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 6889129)

  • 21. Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia.
    Löscher W; Gerdes C; Richter A
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):365-74. PubMed ID: 7845474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porcine malignant hyperthermia: false negatives in the halothane test.
    Gallant EM; Rempel WE
    Am J Vet Res; 1987 Mar; 48(3):488-91. PubMed ID: 3565905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cortisol levels in pigs susceptible and resistant to malignant hyperthermia.
    Mitchell G; Heffron JJ
    J S Afr Vet Assoc; 1981 Jun; 52(2):109-12. PubMed ID: 6268785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dantrolene sodium is able to reduce the resting ionic [Ca2+]i in muscle from humans with malignant hyperthermia.
    López JR; Medina P; Alamo L
    Muscle Nerve; 1987 Jan; 10(1):77-9. PubMed ID: 3561441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Malignant hyperthermia: current perspectives.
    Felice-Johnson J; Sudds T; Bennett G
    Am J Hosp Pharm; 1981 May; 38(5):646-51. PubMed ID: 7282692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Halothane testing for malignant hyperthermia in swine: dose-response effects.
    McGrath CJ; Lee JC; Rempel WE
    Am J Vet Res; 1984 Sep; 45(9):1734-6. PubMed ID: 6497130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Halothane-induced malignant hyperthermia (MH) in the Belgian Landrace breed of pigs: some findings concerning the role of subcellular fractions (author's transl)].
    van den Hende C; Muylle E; Vlaminck K; Oyaert W
    Tijdschr Diergeneeskd; 1980 Dec; 105(24):1054-9. PubMed ID: 6449758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple-pulse stimulation and dantrolene in malignant hyperthermia.
    Quinlan JG; Wedel DJ; Iaizzo PA
    Muscle Nerve; 1990 Oct; 13(10):904-8. PubMed ID: 2233846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection from halothane-induced porcine malignant hyperthermia syndrome by droperidol.
    McGrath CJ; Rempel WE; Jessen CR; Addis PB; Crimi AJ; Ruff J
    Lab Anim Sci; 1980 Dec; 30(6):992-5. PubMed ID: 7464035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine malignant hyperthermia susceptibility: halothane-induced increase in cytoplasmic free calcium in lymphocytes.
    O'Brien PJ; Kalow BI; Brown BD; Lumsden JH; Jacobs RM
    Am J Vet Res; 1989 Jan; 50(1):131-5. PubMed ID: 2919818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium.
    Harrison GG
    Br J Anaesth; 1975 Jan; 47(1):62-5. PubMed ID: 1148076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New findings and experiences in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1986 Jan; 35(1):1-9. PubMed ID: 2938519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fulminating malignant hyperthermia in swine--an alternative therapy concept].
    Henke VJ; Köhle M; Matiasek K; Beckurts TE; Sarmiento AM; Blümel G; Erhardt W
    Dtsch Tierarztl Wochenschr; 1995 Jan; 102(1):57-9. PubMed ID: 7781543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium].
    Noda B; Higa K; Naitoh H; Dan K
    Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707
    [No Abstract]   [Full Text] [Related]  

  • 36. Myoplasmic free [Ca2+] during a malignant hyperthermia episode in swine.
    López JR; Allen PD; Alamo L; Jones D; Sreter FA
    Muscle Nerve; 1988 Jan; 11(1):82-8. PubMed ID: 3340102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porcine malignant hyperthermia susceptibility: erythrocytic osmotic fragility.
    O'Brien PJ; Rooney MT; Reik TR; Thatte HS; Rempel WE; Addis PB; Louis CF
    Am J Vet Res; 1985 Jul; 46(7):1451-6. PubMed ID: 4026025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A halothane-induced biochemical defect in muscle of normal and malignant hyperthermia-susceptible Landrace pigs.
    Mitchell G; Heffron JJ; van Rensburg AJ
    Anesth Analg; 1980 Apr; 59(4):250-6. PubMed ID: 7189363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Porcine malignant hyperthermia--failure of dantrolene dose response to diagnose susceptibility (halothane effect).
    Flewellen EH; Nelson TE; Bee DE
    Can Anaesth Soc J; 1980 Jan; 27(1):16-21. PubMed ID: 7353186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of brain electrical activity during treatment of porcine malignant hyperthermia with dantrolene.
    Kochs E; Hoffman WE; Schulte am Esch J
    Br J Anaesth; 1993 Dec; 71(6):881-4. PubMed ID: 8280559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.